A Cyclin-Dependent Kinase Inhibitor, p16^{INK4A}, Induces Apoptosis in The Human Cancer Cells.

Cyclin-dependent Kinase저해 단백질 p16^{INK4A}의 인체 암세포에서의 세포사멸 유도 활성

  • 김민경 (한양대학교 의과대학 유전학교실) ;
  • 이철훈 (한양대학교 의과대학 유전학교실)
  • Published : 2004.03.01

Abstract

Previously, we synthesized a novel Cyclin-dependent kinase inhibitor, MCS-5A. Also, we investigated the involvement of cell cycle regulatory events during MCS-5A-mediated apoptosis in HL-60(+p16/-p53) cells with up-regulation of p16 protein expression. In contrast, apoptosis was not observed in A549(-p16/+p53) cells. Therefore we propose that $p16^{INK4A}$ is a key enzyme for inducing apoptosis. In the present studies, we have explored the mechanism of $p16^{INK4A}$ -mediated cytotoxicity and the role of p16.sup INK4A/ overexpression in the induction of apoptosis in human tumor cells. The tumor suppressor gene $p16^{INK4A}$ is known as a cyclin-dependent kinase inhibitor (CKI) and cell cycle regulator. We expressed wild type $p16^{INK4A}$ in pcDNA3.1 vector and then transfected into non-small cell lung cancer (NSCLC) cell expressing different statue of p16$^{INK4A}$, p53 gene〔A549(-p16/+p53), H1299(-p16/-p53) and HeLa(+pl6/+p53) cell line〕. TUNEL assay (including propidium iodide staining following transfection of these cell line with pcDNA3.1-pl6) indicate that p16$^{INK4A}$-mediated cytotoxicity was associated with apoptosis. This is supported by studies demonstrating an induction of caspase 3 cleavage due to the transfection of A549, H1299 and HeLa cells with pcDNA3.1-pl6. These results suggest that p16$^{INK4A}$ has a new function of inducing apoptosis which is not related with the function of tumor suppressor gene p53.

Keywords

pl6^{INK4A};Apoptosis;Cell cycle arrest

References

  1. Cancer Res. v.12 Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium Gey,G.O.;W.D.Coffman;M.T.Kubicek
  2. Nature v.375 Retinoblastoma-protein-dependent cell cycle inhibition by the tumour suppressor p16 Lukas,J.;D.Parry;L.Aagaard;D.J.Mann,;J.Bartkova;M.Strauss;G.Peters;J.Bartek
  3. Nature v.366 A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Serrano,M.;G.J.Hannon;D.Beach
  4. Nature v.375 Tumour derived p16 alleles encoding proteins defective in cell-cycle inhibition Koh,J.;G.H.Enders;B.D.Dynlacht;E.Harlow
  5. Proc. Natl. Acad. Sci. v.93 The molecular biology of appoptosis Vidal,A.;K.Andrew
  6. Science v.264 A cell cycle regulator potentially involved in genesis of many tumor types Kamb,A.;N.A.Gruis;J.Weaver-Feidhaus;Q.Liu;K.Harshman;S.V.Tavtigian;E.Stockert;R.S.III Day,B.E.Johnson;M.H.Skolnick
  7. Curr. Opin. Genet. Dev. v.9 The INK4a/ARF locus and its two gene products Sharpless,Norman E.;Ronald A.DePinho
  8. J. Mol. Biol. v.285 Stability and Folding of the Tumor Suppressor Protein p16 Tang,Kit S.;Benjamin J.Guralinick;Wooi Koon Wang;Alan R.Fersht;Laura S.Itzhaki
  9. Curr. Opin. Genet. Dev. v.10 Tumor suppressor genes Macleod,Kay
  10. Trends. biochem. Sci. v.23 The INK4a/AFR tumor suppressor: one gene-two products- two pathways Chin,Lynda;Jason P.;Ronald.A.DePinho
  11. Proc. Natil. Acad. Sci. USA v.93 The molecular biology of apoptosis Vaux,D.L.;A.Strasser
  12. Nature v.362 Thymocyte apoptosis induced by p53-dependent and independent pathway Clarke,G.O.;W.D.Coffiman;M.T.Kubicek
  13. Gene v.247 Cell-cycle inhibitors: three families united by a common cause Vidal,A.;K.Andrew
  14. Nature v.362 p53 is required for radiation-induced apoptosis in mouse thymocytes Lowe,S.W.;E.M.Schmitt;S.W.Smith;B.A.Osborne;T.Jacks
  15. Int. J. Hematol v.68 no.1 Mechanisms involved in chemotherapyinduced apoptosis and their implication in cancer chemotherapy Kamesaki,H.
  16. J. Cell. Physiol. v.181 The p53 Pathway and apoptosis Burns,Timothy F.;Wafik S.El-deiry
  17. Cell v.80 Tumor suppressor p53 is a direct transcriptional activator of the human box gene Miyashita,T.;J.C.Reed
  18. Oncogene v.19 Down-regulation of bcl-2 is associated with $p16^{INK4a}$-mediated apoptosis in non-small cell lung cancer cell Kataoka,M.;S.Wiehle;F.Spitz;G.Schumacher;J.A.Roth;R.J.Cristiano
  19. Nucleosides Nucleotides v.18 Synthesis of L-Sangivamycin and Toyocamycin analogues and their inhibitory activities of Ser/Thr protein kinases Chun,M.W.;D.H.Shin;s.Y.Song;Y.H.Lee;C.H.Lee;L.S.Jeong;S.K.Lee
  20. Science v.246 A frequent target for genetic abnormalities in lung cancer Takahashi,T.
  21. Proc. Natl. Acad. Sci. v.88 The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines Scheffiner,M.
  22. Mol. Cells v.6 A Specific Inhibitor of Cyclin-Dependent Protein Kinases, CDC2 and CDK2 Park,S.;J.Cheon;Y.Lee;J.Park;K.Lee;C.-H.Lee;S.Lee
  23. Mol. Cell. Biol. v.19 Induced expression of p16(INK4A) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complex McConnell,B.B.;F.J.Gregory;F.J.Stott;E.Hara;G.Peters
  24. Cell Death. Differ v.7 Induction of apoptosis in p1$6^{INK4A}$ mutant cell line by adenovirus-mediated overexpression of $6^{INK4A}$ protein Kim,M.;Y.Katayose;L.Rojanala;S.Shah;M.Sgagias
  25. Molecular Cloning: A Laboratory maunal, 3th ed. Sambrook,J.;D.W.Russell
  26. Biochim, Biophys. Acta. v.1378 The p16INK4a/CDKN2A tumor suppressor and its relatives Ruas,M.;G.Peters